<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE"><gtr:id>E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE</gtr:id><gtr:name>Gene Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE"><gtr:id>E78CD8B1-DDE5-436E-BD12-5EA768E4C6FE</gtr:id><gtr:name>Gene Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/60B70014-0DA9-42DD-834E-9D5622E53D24"><gtr:id>60B70014-0DA9-42DD-834E-9D5622E53D24</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Benjamin</gtr:otherNames><gtr:surname>Ascher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9387F657-B9DB-4164-B995-7D2147B97EC5"><gtr:id>9387F657-B9DB-4164-B995-7D2147B97EC5</gtr:id><gtr:firstName>Sharon</gtr:firstName><gtr:surname>Peacock</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/877C0FAD-13BC-4F15-A199-F32B4E46D637"><gtr:id>877C0FAD-13BC-4F15-A199-F32B4E46D637</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Blundell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FM026302%2F1"><gtr:id>17A20E3E-D91B-4EDE-A2EF-DD050538FB9C</gtr:id><gtr:title>Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M026302/1</gtr:grantReference><gtr:abstractText>Tuberculosis is recognised as one of Brazil's leading infectious diseases, with over 70,000 cases notified each year. There has been a significant increase in the number of diagnosed Multidrug resistant TB cases, with 10% of those also resistant to the two most important second---line class drugs (XDR-TB). This project aims to build upon existing collaborative programs on understanding effects of mutations, and on combating multidrug resistant and extensively drug resistant (MDR and XDR respectively) tuberculosis (TB). The two nodes, Brazil and UK, have complementary skills that encompass epidemiology, human and pathogen genetics, bioinformatics, structural biology and drug discovery. This multidisciplinary combination will facilitate the development of a novel platform to rapidly identify resistant TB from genomic sequencing. Novel mechanisms of drug resistance in TB will be explored using cutting edge techniques and correlated with clinical outcomes. This will help guide more suitable patient treatment, public health policies and future drug discovery efforts, with potential to bring benefit to individuals and public health in Brazil and UK, providing solutions to a problem that affects a third of the world's population.</gtr:abstractText><gtr:technicalSummary>Tuberculosis is recognised as one of Brazil's leading infectious diseases, with over 70,000 cases notified each year. There has been a significant increase in the number of diagnosed MDR-TB cases, with 10% of those also resistant to the two most important second-line class drugs (XDR-TB). In line with WHO Stop TB Strategy, our partnership will focus on emerging sequence-based diagnostics to improve accuracy of individual patient treatment. This project aims to build upon existing collaborative programs on understanding effects of mutations, and on combating multidrug resistant and extensively drug resistant (MDR and XDR respectively) tuberculosis (TB). The two nodes, Brazil and UK, have complementary skills that encompass epidemiology, human and pathogen genetics, bioinformatics, structural biology and drug discovery. This multidisciplinary combination will facilitate the development of a novel platform to rapidly identify resistant TB from genomic sequencing. Novel mechanisms of drug resistance in TB will be explored using cutting edge techniques and correlated with clinical outcomes. This will help guide more suitable patient treatment, public health policies and future drug discovery efforts, with potential to bring benefit to individuals and public health in Brazil and UK, providing solutions to a problem that affects a third of the world's population.

Specific aims:
i)Enhance an existing research partnership, bringing equitable scientific and health benefits to Brazil and the UK.
ii)Develop a novel and effective platform to identify drug-resistant TB.
iii)Facilitate training and knowledge transfer, enhancing independent research capacity and fostering international collaborative projects.</gtr:technicalSummary><gtr:potentialImpactText>N/A</gtr:potentialImpactText><gtr:fund><gtr:end>2016-01-29</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-01-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>49396</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>A44D41E7-05D6-4F4D-A213-65320BEF9E7C</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>77CE71FC-4AF0-4CBD-B91F-280D0D109580</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:department><gtr:description>Shorten-TB</gtr:description><gtr:id>FC5738CF-771F-4DD7-9025-208816C21764</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Drug screening and development</gtr:partnerContribution><gtr:piContribution>Analysis of structure, function and druggability of targets in tuberculosis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>AA800AE0-DB15-4C2C-8D88-608261EA809C</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Institute of Infectious Disease and Molecular Medicine (IIDMM)</gtr:department><gtr:description>Shorten-TB</gtr:description><gtr:id>D2CEDC9F-AD5E-40B8-93A5-E2F7E0C4EE68</gtr:id><gtr:impact>None yet</gtr:impact><gtr:partnerContribution>Drug screening and development</gtr:partnerContribution><gtr:piContribution>Analysis of structure, function and druggability of targets in tuberculosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>C30900FE-112E-4F14-91AD-14CC7400B3F7</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Groningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>D7A83614-CD81-48AE-B915-BCEC0CE35CA6</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gene Laboratory</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Laborat&amp;oacute;rio Gene</gtr:description><gtr:id>AF88F20B-77D6-400B-B089-53D49E2C5297</gtr:id><gtr:impact>This is multi-disciplinary- involving clinicians, geneticists, bioinformaticians and experimentalists.

To date one paper has been submitted.</gtr:impact><gtr:partnerContribution>Identification of novel genetic mutations and validation of our predictions.</gtr:partnerContribution><gtr:piContribution>Analysing genetic mutations identified by Professor Sergio Pena and his team.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Biological Sciences Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Cambridge UKCRC Consortium</gtr:description><gtr:id>A024393F-0BF7-48DC-86E7-D3DB76E17DBF</gtr:id><gtr:impact>The publications to date are listed under this grant.</gtr:impact><gtr:partnerContribution>The partners each bring unique skills to the project, including informatics analysis, modelling, and evolutionary biology.</gtr:partnerContribution><gtr:piContribution>The Cambridge UKCRC Consortium is funded via the UKCRC TIRI to develop and implement whole genome sequencing of MRSA in clinical practice. I lead this Consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Wellcome Trust Sanger Institute Genomics for Clinicians course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>725B655B-E1F4-4830-BAAB-5E9055243DDC</gtr:id><gtr:impact>A talk on pathogen genomics to clinical professionals attending a 1 week course to gain an understanding of the application of genomics to clinical practice</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Tom Blundell appointed 8th Distinguished Technopreneur  2015, Singapore</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>14BA2DF6-D24C-4821-9B4D-FD591B3AA456</gtr:id><gtr:impact>A discussion by Tom Blundell of research ecosystems, based on experience of forming companies in London and Cambridge, and looking at options for Singapore.

Discussions with Deputy Prime Minister of Singapore; visit of Head of Research to my company on the Science Park</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.science50.com.sg/dts.html</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Therapeutics Forum: Pharma, Biotech, Clinical School and University</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B2EDE6A8-7634-40E2-849C-8A1D93D76D18</gtr:id><gtr:impact>A short presentation by Tom Blundell to a mixed group involved in research ecosystems. Exemplified by foundation of Astex in my lab, progression to science park, candidate drugs into man, phase III, sale for $886million.

The second talk given by Sir Greg Winter,</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.onenucleus.com/cambridge-new-therapeutics-forum</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Antimicrobial Resistance Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>71BF743C-A9E6-4F85-B765-333EA73D3506</gtr:id><gtr:impact>Workshop discussing with policy makers, clinicians, scientists and research students in order to understand and cobalt impacts of antimicrobial resistance, mainly in tuberculosis</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit by Tom Blundell (Suffolk)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F8063AE1-3C8A-4EB8-9BC2-82081CC27614</gtr:id><gtr:impact>Talk and opening a plaque to Dorothy Hodgkin commemorating her attendance at a secondary school in Beccles. Designed to encourage young students to do science - with local MP and relatives of Dorothy. Extensive media coverage in local papers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Weaver Endowed Lecture at UC Davis California</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9F946A88-AC3B-4CF6-A791-BA4E70E0F3B4</gtr:id><gtr:impact>A general lecture to a broad audience about the contributions of my science to drug discovery over the past 50 years</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Two lectures in University Pretoria, first to broad audience of students, policy makers, teachers; the second to students from the local Ndebele township</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0A784253-5DA5-4235-B445-E4D87DAA1A38</gtr:id><gtr:impact>Lectures leading to small discussions with groups of mainly Ndebele speaking undergraduate students; followed by visit to local township for discussions mediated by Dr Gugu Motshwene, and ex-tudent now lecturer in the University of Pretoria</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science festival event (2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0F43065B-54A3-4A74-A575-E8EE900E18BA</gtr:id><gtr:impact>Sharon Peacock organised for the actor Stephen McGann to give a presentation as part of the Cambridge Science Festival 2015 entitled: 'Infectious knowledge:science in popular culture'
He is a keen science communicator and spoke about the power of science and its place at the heart of public conversation. There was a good discussion between presenter and audience at the end. 
Feedback gathered at the end of the talk was generally very positive:
This event was really well suited to an audience of teens and could have been marketed as such.
Absolutely brilliant, interesting lecture! 
Really enjoyed this event.
Infectious Knowledge: I was disappointed in the simplistic approach to science, but that's popular culture.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/system/files/csf_2015_web_programme.pdf</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Indian National Science Congress 2016, Mysore</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EAABAEBE-3B2B-4DAC-8DBC-0BE3A265A0E2</gtr:id><gtr:impact>General theme: Science &amp;amp; Technology for Indigenous Development in India. Tom Blundell Plenary Lecturer on Drug discovery for infectious disease in India where budgets have to be low. Open Source Drug Discovery, Biotech Spin-outs and Academia in Research Ecosystems</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.isc103.in</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BIOINFORM?TICA ESTRUTURAL DE PROTE?NAS: MODELOS, ALGORITMOS E APLICA??ES BIOTECNOL?GICAS, Belo Horizonte, Brasil</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>55BFD23A-BA40-4BF9-ACF1-F8799B086FA4</gtr:id><gtr:impact>A joint Brazil-UK workshop bringing together discussion human genetics and race in Brazil with our analyses of the effects of genome mutations on genetic disease, cancer and antimicrobial resistance</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>2C091D69-3977-46C7-8298-8B8A7D79CE6A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1588479</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC antimicrobial resistance collaboration</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B9F2CF32-F717-42D7-94A2-0567363567D9</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1159686</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton Fund MRC-UK DBT-India</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>RG77600, Project: RCAG/623</gtr:fundingRef><gtr:id>B02B1F37-519C-451B-9252-1D7E25C6B596</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Newton Researcher Links Workshop Grants</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>216419211</gtr:fundingRef><gtr:id>633F645C-8030-4614-B04D-2FE1029B6F8A</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>C4B7FB58-66CC-4DA8-A8C0-FF630C8497F5</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1007929</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge-Chennai centre partnership on antimicrobial resistant tuberculosis</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2974C744-5BA3-4E46-8514-942D3358F6DB</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11999339</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR/BRC</gtr:department><gtr:description>UK Rapid Support Team</gtr:description><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>4A8D3C0D-8405-4733-AC32-FA4A7679DD3D</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A database of protein interactions, including protein-protein, protein ligand</gtr:description><gtr:id>8EBC5328-344D-42D1-814C-5EECFB4FCB4B</gtr:id><gtr:impact>Used to understand drug interactions with protein targets</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Credo</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://marid.bioc.cam.ac.uk/credo</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>pkCSM is a novel, freely available method for predicting the pharmacokinetics and toxicity of small molecules- major limiting factors in drug development.</gtr:description><gtr:id>5B0BEC38-E1D2-4E89-A385-253D3A84C467</gtr:id><gtr:impact>The server has been reviewed in a commentary in Science Translational Medicine, and is currently receiving over 7000 hits/month from academic and pharmaceutical sites around the world.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>pkCSM</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/pkcsm/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Database of the structural proteome of Mycobacterium tuberculosis</gtr:description><gtr:id>C62CF254-EF55-444E-8346-157F2C42D2B7</gtr:id><gtr:impact>Helpful in understanding the druggability of targets for antibacterials for tuberculosis</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Chopin</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://mordred.bioc.cam.ac.uk/chopin/about</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A machine learning approach to understanding the mechanisms by which mutations affect human genetic disease, drug resistance in cancer and antimicrobial resistance in human and infectious disease</gtr:description><gtr:id>AB855AE0-72A6-4DCA-8AD8-47A0D79DDF6E</gtr:id><gtr:impact>Demonstration that both genetic disease and drug resistance mechanisms include allosteric and protein interface affects, leading to suggestions about novel therapeutic mechanisms.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mCSM and mCSMlig</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/mcsm/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Machine learning approach to predicting the impacts of mutations on protein stability and interactions with other proteins, nucleic acids, and small molecule ligands.</gtr:description><gtr:id>24867682-39FB-401A-B3E9-23AD7E4FACE3</gtr:id><gtr:impact>It has significant impact on understanding mutations in genetic disease and drug resistance</gtr:impact><gtr:title>mCSM</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://bleoberis.bioc.cam.ac.uk/mcsm/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>An updated webserver for the improved SDM, used for predicting the effects of mutations on protein stability. We have updated the environment-specific amino-acid substitution tables based on the current expanded PDB (a 5 fold increases in information), and introduced new residue conformations and interaction parameters, including packing density and residue depth.</gtr:description><gtr:id>B0ADE3C8-EA3D-421A-8B81-0E7B2796ABD8</gtr:id><gtr:impact>The updated server has been extensively tested using a wide benchmark containing 2690 point mutations from 132 different protein structures. Using an established benchmark, the revised method correlated well against the hypothetical reverse mutations, better than comparable methods built using machine-learning approaches, highlighting the strength of our knowledge-based approach for identifying stabilising mutations. Given a PDB file (a Protein Data Bank file format containing the three-dimensional coordinates of the protein atoms), and a point mutation, the server calculates the stability difference score between the wildtype and mutant protein.</gtr:impact><gtr:title>sdm</gtr:title><gtr:type>Webtool/Application</gtr:type><gtr:url>http://structure.bioc.cam.ac.uk/sdm2</gtr:url><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E742E480-DEA6-4F7D-A567-0F55D2FD30A7"><gtr:id>E742E480-DEA6-4F7D-A567-0F55D2FD30A7</gtr:id><gtr:title>Mutations at protein-protein interfaces: Small changes over big surfaces have large impacts on human health.</gtr:title><gtr:parentPublicationTitle>Progress in biophysics and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0338972eb64b2c9188c2e8617d57c46"><gtr:id>e0338972eb64b2c9188c2e8617d57c46</gtr:id><gtr:otherNames>Jubb HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0079-6107</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FE0B18B-B924-44B7-9EC4-FCCCE87C97A8"><gtr:id>7FE0B18B-B924-44B7-9EC4-FCCCE87C97A8</gtr:id><gtr:title>Structure-guided, target-based drug discovery - exploiting genome information from HIV to mycobacterial infections.</gtr:title><gtr:parentPublicationTitle>Postepy biochemii</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6dbdbde4ac8e3cf1a59a1e55e70fb328"><gtr:id>6dbdbde4ac8e3cf1a59a1e55e70fb328</gtr:id><gtr:otherNames>Malhotra S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0032-5422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E293C67-F8B1-40ED-9805-F115B759FD06"><gtr:id>8E293C67-F8B1-40ED-9805-F115B759FD06</gtr:id><gtr:title>mCSM-lig: quantifying the effects of mutations on protein-small molecule affinity in genetic disease and emergence of drug resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/027ED68C-4059-4582-9719-5F86AF1CFB2D"><gtr:id>027ED68C-4059-4582-9719-5F86AF1CFB2D</gtr:id><gtr:title>Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e0338972eb64b2c9188c2e8617d57c46"><gtr:id>e0338972eb64b2c9188c2e8617d57c46</gtr:id><gtr:otherNames>Jubb HC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A4F9CA1-E1E8-45D4-8D96-6876D5FF1034"><gtr:id>3A4F9CA1-E1E8-45D4-8D96-6876D5FF1034</gtr:id><gtr:title>Targeting tuberculosis using structure-guided fragment-based drug design.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c71d23a1158640e848407ba21616708"><gtr:id>6c71d23a1158640e848407ba21616708</gtr:id><gtr:otherNames>Mendes V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24B207F7-22AB-42A3-A789-0A49FA139368"><gtr:id>24B207F7-22AB-42A3-A789-0A49FA139368</gtr:id><gtr:title>mCSM-AB: a web server for predicting antibody-antigen affinity changes upon mutation with graph-based signatures.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a71b52ab21ada6778475ab8ff066a341"><gtr:id>a71b52ab21ada6778475ab8ff066a341</gtr:id><gtr:otherNames>Pires DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A57C8A1-A39C-47B0-8097-12C83A5F070C"><gtr:id>3A57C8A1-A39C-47B0-8097-12C83A5F070C</gtr:id><gtr:title>Ubiquitin-Dependent Modification of Skeletal Muscle by the Parasitic Nematode, Trichinella spiralis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e96854e6178e0974d5128fda0de195f4"><gtr:id>e96854e6178e0974d5128fda0de195f4</gtr:id><gtr:otherNames>White RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/709264DC-79DD-417E-AD66-3ED7EB8E5367"><gtr:id>709264DC-79DD-417E-AD66-3ED7EB8E5367</gtr:id><gtr:title>Flexibility and small pockets at protein-protein interfaces: New insights into druggability.</gtr:title><gtr:parentPublicationTitle>Progress in biophysics and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2dfe990ea4c3b7049f41e47d392f389"><gtr:id>f2dfe990ea4c3b7049f41e47d392f389</gtr:id><gtr:otherNames>Jubb H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0079-6107</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70A4954A-47B3-4F70-A854-03315FB1F3FD"><gtr:id>70A4954A-47B3-4F70-A854-03315FB1F3FD</gtr:id><gtr:title>The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.</gtr:title><gtr:parentPublicationTitle>ACS infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/00d7673f8c199287b692989e5f71228e"><gtr:id>00d7673f8c199287b692989e5f71228e</gtr:id><gtr:otherNames>Singh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2373-8227</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M026302/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes><gtr:rcukProgramme><gtr:id>C11BDEA9-7D9D-4728-B6A9-31032921B328</gtr:id><gtr:text>Newton</gtr:text></gtr:rcukProgramme></gtr:rcukProgrammes></gtr:project></gtr:projectComposition></gtr:projectOverview>